Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Aug 30, 2024

SELL
$2.35 - $4.01 $14,100 - $24,060
-6,000 Closed
0 $0
Q3 2020

Aug 30, 2024

BUY
$1.81 - $5.53 $10,860 - $33,180
6,000 New
6,000 $13.7 Million

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0

About GENOCEA BIOSCIENCES, INC.


  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.